RTTNews | Oct 5, 2020 09:55AM EDT

09:54 Monday, October 5, 2020 (RTTNews.com) - Shares of Enlivex Therapeutics Ltd. (ENLV) are up more than 30% Monday morning, continuing the momentum following positive Covid-19 drug results.

On October 1, the company had reported positive top-line results from the study of its Covid-19 drug candidate, Allocetra.

The stock gained nearly 60% in the last two days.

Enlivex stock is currently trading at $14.12, nearing to its 52-week high of $16.94.

Read the original article on RTTNews ( https://www.rttnews.com/3133847/stock-alert-enlivex-therapeutics-rise-continues.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved